Back to Agenda

Looking forward to this session? Share it!

  • Discuss the evolving nature of US environment leading to an increase in use of Real-World Evidence (RWE)
  • Evaluate the role of RWE in Oncology Product Registration in the US
  • Identify opportunities in leveraging RWE to support access, reimbursement, and commercialization in the US